Works matching IS 00070920 AND DT 2024 AND VI 130 AND IP 5

Results: 18
    1

    Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?

    Published in:
    British Journal of Cancer, 2024, v. 130, n. 5, p. 777, doi. 10.1038/s41416-023-02563-w
    By:
    • Contreras-Toledo, Débora;
    • Jiménez-Fonseca, Paula;
    • López, Carlos López;
    • Montes, Ana Fernández;
    • López Muñoz, Ana María;
    • Vázquez Rivera, Francisca;
    • Alonso, Vicente;
    • Alcaide, Julia;
    • Salvà, Francesc;
    • Covela Rúa, Marta;
    • Guillot, Mónica;
    • Martín Carnicero, Alfonso;
    • Jimeno Mate, Raquel;
    • Cameselle García, Soledad;
    • Asensio Martínez, Elena;
    • González Astorga, Beatriz;
    • Fernandez-Diaz, Amaya B.;
    • González Villaroel, Paula;
    • Virgili Manrique, Anna C.;
    • Melián Sosa, Marcos
    Publication type:
    Article
    2
    3
    4
    5
    6

    Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASE.

    Published in:
    British Journal of Cancer, 2024, v. 130, n. 5, p. 769, doi. 10.1038/s41416-023-02564-9
    By:
    • Gouriou, Claire;
    • Lemanski, Claire;
    • Pommier, Pascal;
    • Le Malicot, Karine;
    • Saint, Angélique;
    • Rivin del Campo, Eleonor;
    • Evin, Cécile;
    • Quero, Laurent;
    • Regnault, Pauline;
    • Baba-Hamed, Nabil;
    • Ronchin, Philippe;
    • Crehange, Gilles;
    • Tougeron, David;
    • Menager-Tabourel, Elodie;
    • Diaz, Olivia;
    • Hummelsberger, Michael;
    • de la Rocherfordiere, Anne;
    • Drouet, Franck;
    • Vendrely, Véronique;
    • Lièvre, Astrid
    Publication type:
    Article
    7
    8

    Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies.

    Published in:
    British Journal of Cancer, 2024, v. 130, n. 5, p. 869, doi. 10.1038/s41416-023-02561-y
    By:
    • Blanco, Ester;
    • Silva-Pilipich, Noelia;
    • Bocanegra, Ana;
    • Chocarro, Luisa;
    • Procopio, Antonio;
    • Ausín, Karina;
    • Fernandez-Irigoyen, Joaquín;
    • Fernández, Leticia;
    • Razquin, Nerea;
    • Igea, Ana;
    • Garnica, Maider;
    • Echaide, Miriam;
    • Arasanz, Hugo;
    • Vera, Ruth;
    • Escors, David;
    • Smerdou, Cristian;
    • Kochan, Grazyna
    Publication type:
    Article
    9

    Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer.

    Published in:
    British Journal of Cancer, 2024, v. 130, n. 5, p. 861, doi. 10.1038/s41416-023-02560-z
    By:
    • Young Han, Chae;
    • Bedia, Jacob S.;
    • Yang, Wei-Lei;
    • Hawley, Sarah J.;
    • Bergan, Lindsay;
    • Hopper, Marika;
    • Celestino, Joseph;
    • Guo, Jing;
    • Gornet, Terrie G.;
    • Soosaipillai, Antoninus;
    • Yang, Hailing;
    • Doskocil, Samantha D.;
    • Lokshin, Anna E.;
    • Handy, Beverly C.;
    • Diamandis, Eleftherios P.;
    • Moore, Richard G.;
    • Lu, Karen H.;
    • Lu, Zhen;
    • Anderson, Karen S.;
    • Drescher, Charles W.
    Publication type:
    Article
    10
    11
    12

    Intratumoral presence of the genotoxic gut bacteria pks<sup>+</sup>E. coli, Enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum and their association with clinicopathological and molecular features of colorectal cancer.

    Published in:
    British Journal of Cancer, 2024, v. 130, n. 5, p. 728, doi. 10.1038/s41416-023-02554-x
    By:
    • Joo, Jihoon E.;
    • Chu, Yen Lin;
    • Georgeson, Peter;
    • Walker, Romy;
    • Mahmood, Khalid;
    • Clendenning, Mark;
    • Meyers, Aaron L.;
    • Como, Julia;
    • Joseland, Sharelle;
    • Preston, Susan G.;
    • Diepenhorst, Natalie;
    • Toner, Julie;
    • Ingle, Danielle J.;
    • Sherry, Norelle L.;
    • Metz, Andrew;
    • Lynch, Brigid M.;
    • Milne, Roger L.;
    • Southey, Melissa C.;
    • Hopper, John L.;
    • Win, Aung Ko
    Publication type:
    Article
    13
    14
    15
    16

    Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial.

    Published in:
    British Journal of Cancer, 2024, v. 130, n. 5, p. 788, doi. 10.1038/s41416-023-02525-2
    By:
    • Hogarty, Michael D.;
    • Ziegler, David S.;
    • Franson, Andrea;
    • Chi, Yueh-Yun;
    • Tsao-Wei, Denice;
    • Liu, Kangning;
    • Vemu, Rohan;
    • Gerner, Eugene W.;
    • Bruckheimer, Elizabeth;
    • Shamirian, Anasheh;
    • Hasenauer, Beth;
    • Balis, Frank M.;
    • Groshen, Susan;
    • Norris, Murray D.;
    • Haber, Michelle;
    • Park, Julie R.;
    • Matthay, Katherine K.;
    • Marachelian, Araz
    Publication type:
    Article
    17

    Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis.

    Published in:
    British Journal of Cancer, 2024, v. 130, n. 5, p. 808, doi. 10.1038/s41416-023-02517-2
    By:
    • Le Teuff, Gwénaël;
    • Cozic, Nathalie;
    • Boyer, Jean-Christophe;
    • Boige, Valérie;
    • Diasio, Robert B.;
    • Taieb, Julien;
    • Meulendijks, Didier;
    • Palles, Claire;
    • Schwab, Matthias;
    • Deenen, Maarten;
    • Largiadèr, Carlo R.;
    • Marinaki, Anthony;
    • Jennings, Barbara A.;
    • Wettergren, Yvonne;
    • Di Paolo, Antonello;
    • Gross, Eva;
    • Budai, Barna;
    • Ackland, Stephen P.;
    • van Kuilenburg, André B. P.;
    • McLeod, Howard L.
    Publication type:
    Article
    18